79 results on '"Menéndez, Rosario"'
Search Results
2. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)
3. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
4. Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia
5. Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired Pneumonia: Development and Validation Study
6. Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection
7. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
8. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study
9. Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
10. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations
11. Cardiovascular Events During and After Bronchiectasis Exacerbations and Long-term Mortality
12. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients
13. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort
14. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias
15. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection
16. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
17. RIBRON: The Spanish online bronchiectasis registry. Characterization of the first 1912 patients
18. RIBRON: el registro español informatizado de bronquiectasias. Caracterización de los primeros 1.912 pacientes
19. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
20. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia
21. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies
22. Early and late cardiovascular events in patients hospitalized for community-acquired pneumonia
23. Eventos cardiovasculares tempranos y tardíos en pacientes ingresados por neumonía adquirida en la comunidad
24. Neumonía adquirida en la comunidad. Normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Actualización 2020
25. Neumonía intrahospitalaria. Normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Actualización 2020
26. Community-Acquired Pneumonia Patients at Risk for Early and Long-term Cardiovascular Events Are Identified by Cardiac Biomarkers
27. Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis
28. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality
29. An international perspective on hospitalized patients with viral community-acquired pneumonia
30. Pneumonic and non-pneumonic exacerbations in bronchiectasis: Clinical and microbiological differences
31. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia
32. Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia
33. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study
34. Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome
35. Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients
36. Severity and outcomes of community acquired pneumonia in asthmatic patients
37. Guía de consenso para el abordaje de la neumonía adquirida en la comunidad en el paciente anciano
38. Impact of microbial ecology on accuracy of surveillance cultures to predict multidrug resistant microorganisms causing ventilator-associated pneumonia
39. Tobacco Smoking Increases the Risk for Death From Pneumococcal Pneumonia
40. Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
41. Pneumonic and Nonpneumonic Exacerbations of COPD: Inflammatory Response and Clinical Characteristics
42. Impact of Age and Comorbidity on Cause and Outcome in Community-Acquired Pneumonia
43. Systemic Inflammatory Pattern of Patients With Community-Acquired Pneumonia With and Without COPD
44. Thrombocytosis Is a Marker of Poor Outcome in Community-Acquired Pneumonia
45. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
46. Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia
47. The Impact of Guidelines on the Outcomes of Community-acquired and Ventilator-associated Pneumonia
48. Community-Acquired Pneumonia. New Guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)
49. Neumonía adquirida en la comunidad. Nueva normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
50. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.